CHI3L1 and periodontitis: The progression of chronic periodontitis (CP) can be managed by non-surgical periodontal therapy, and a balance between the host inflammatory mediators and immune response can show the efficacy of periodontal therapy in periodontitis patients.27 It has been proven that YKL-40 levels have both diagnostic and prognostic value for certain diseases.23,26